Literature DB >> 10949927

Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

A Marchio1, P Pineau, M Meddeb, B Terris, P Tiollais, A Bernheim, A Dejean.   

Abstract

To discriminate among the chromosomal abnormalities associated with the etiology of hepatocellular carcinoma (HCC), we performed a comparative genomic hybridization (CGH) analysis on 34 HCCs resected on non-cirrhotic livers from patients serologically negative for both hepatitis B (HBV) and C (HCV) viruses. The results were compared to those of a previous analysis of 50 HCCs selected on the basis of their positivity for HBV infection. The majority of the abnormalities found in the HBV positive cases (losses of chromosome arms 1p, 8p, 6q, 13q and 14q and gains of 1q, 8q, 6p and 17q) were similarly detected in the virus negative specimens. In contrast, a significant decrease (40% on average) was observed for losses at 4q, 16q and 17p in non-viral HCC samples, suggesting that these abnormalities are tightly associated with HBV infection. Thus, in addition to a common pathway towards malignancy, a subset of alterations may preferentially contribute to virus-induced carcinogenesis. In a parallel CGH study of 10 fibrolamellar carcinomas, a rare subtype of HCC, we found in six out of the seven informative cases, gains of chromosome arm 1q. This region, which is also preferentially amplified in non fibrolamellar tumors (58%), may contain an essential proto-oncogene commonly implicated in liver carcinogenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10949927     DOI: 10.1038/sj.onc.1203713

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.

Authors:  Jie Ding; Shenglin Huang; Shunquan Wu; Yingjun Zhao; Linhui Liang; Mingxia Yan; Chao Ge; Jian Yao; Taoyang Chen; Dafang Wan; Hongyang Wang; Jianren Gu; Ming Yao; Jinjun Li; Hong Tu; Xianghuo He
Journal:  Nat Cell Biol       Date:  2010-03-21       Impact factor: 28.824

Review 2.  Hepatocellular carcinoma.

Authors:  Marie-Annick Buendia; Christine Neuveut
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

3.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

4.  Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.

Authors:  A Marchio; B Terris; M Meddeb; P Pineau; A Duverger; P Tiollais; A Bernheim; A Dejean
Journal:  Mol Pathol       Date:  2001-08

5.  Development of hepatocellular carcinoma following treatment with 6-mercaptopurine for ulcerative colitis: investigation of chromosomal aberration by comparative genomic hybridization.

Authors:  Kentaro Nakao; Akira Tsunoda; Yoshinori Shimizu; Koji Takenaka; Koji Morohara; Naoto Suzuki; Katsuo Yamazaki; Takeshi Aoki; Mitsunori Hoshino; Mitsuo Kusano; Eri Kitadai; Toshikazu Kurihara; Yoshiaki Takeuchi; Michio Imawari
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

6.  Molecular genetics of hepatocellular neoplasia.

Authors:  Shilpa Jain; Shashideep Singhal; Peng Lee; Ruliang Xu
Journal:  Am J Transl Res       Date:  2010-01-23       Impact factor: 4.060

7.  Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

Authors:  Joshua N Honeyman; Elana P Simon; Nicolas Robine; Rachel Chiaroni-Clarke; David G Darcy; Irene Isabel P Lim; Caroline E Gleason; Jennifer M Murphy; Brad R Rosenberg; Lydia Teegan; Constantin N Takacs; Sergio Botero; Rachel Belote; Soren Germer; Anne-Katrin Emde; Vladimir Vacic; Umesh Bhanot; Michael P LaQuaglia; Sanford M Simon
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

Review 8.  Natural history of hepatitis-related hepatocellular carcinoma.

Authors:  David-Yiu-Kuen But; Ching-Lung Lai; Man-Fung Yuen
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 9.  Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.

Authors:  Hoang Hai; Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.